A detailed history of Israel Englander (Millennium Management LLC) transactions in Pulmonx Corp stock. As of the latest transaction made, Millennium Management LLC holds 650,234 shares of LUNG stock, worth $4.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
650,234
Previous 804,023 19.13%
Holding current value
$4.12 Million
Previous $10.3 Million 41.21%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$8.71 - $14.65 $1.34 Million - $2.25 Million
-153,789 Reduced 19.13%
650,234 $6.03 Million
Q4 2023

Feb 14, 2024

BUY
$7.89 - $13.14 $1.77 Million - $2.96 Million
224,952 Added 38.85%
804,023 $10.3 Million
Q2 2023

Aug 14, 2023

BUY
$10.78 - $13.65 $6.24 Million - $7.9 Million
579,071 New
579,071 $7.59 Million
Q4 2022

Feb 14, 2023

BUY
$4.92 - $17.35 $323,637 - $1.14 Million
65,780 New
65,780 $555,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.